These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37703344)

  • 1. Barriers and Strategies for Hepatitis B and C Elimination in Pakistan.
    Qureshi H; Mahmood H; Sabry A; Hermez J
    J Infect Dis; 2023 Sep; 228(Suppl 3):S204-S210. PubMed ID: 37703344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress towards elimination of viral hepatitis by 2030 in the WHO Eastern Mediterranean Region, 2019.
    Alaama AS; Khattabi H; Mugisa B; Atta H; Hermez J; Hutin YJ
    Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):862-870. PubMed ID: 35817075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How far are we from viral hepatitis elimination service coverage targets?
    Hutin YJ; Bulterys M; Hirnschall GO
    J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25050. PubMed ID: 29633520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global reporting of progress towards elimination of hepatitis B and hepatitis C.
    Cui F; Blach S; Manzengo Mingiedi C; Gonzalez MA; Sabry Alaama A; Mozalevskis A; Séguy N; Rewari BB; Chan PL; Le LV; Doherty M; Luhmann N; Easterbrook P; Dirac M; de Martel C; Nayagam S; Hallett TB; Vickerman P; Razavi H; Lesi O; Low-Beer D
    Lancet Gastroenterol Hepatol; 2023 Apr; 8(4):332-342. PubMed ID: 36764320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How far is Mexico from Viral Hepatitis Global Health Sector Strategy 2030 targets.
    García-Sepúlveda CA; Laguna-Meraz S; Panduro A
    Ann Hepatol; 2020; 19(2):123-125. PubMed ID: 32138870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting.
    Le LV; Blach S; Rewari B; Chan P; Fuqiang C; Ishikawa N; Sharma M; Mangadan-Konath N; Razavi H; Low-Beer D; Razavi-Shearer D
    Liver Int; 2022 Aug; 42(9):1930-1934. PubMed ID: 34894047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Hepatitis B Collaborators
    Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):796-829. PubMed ID: 35738290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving towards hepatitis B elimination in Gulf Health Council states: From commitment to action.
    Al Awaidy ST; Ezzikouri S
    J Infect Public Health; 2020 Feb; 13(2):221-227. PubMed ID: 31445879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017.
    Lazarus JV; Stumo SR; Harris M; Hendrickx G; Hetherington KL; Maticic M; Jauffret-Roustide M; Tallada J; Simojoki K; Reic T; Safreed-Harmon K;
    J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25052. PubMed ID: 29633562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for a cluster randomised controlled trial of secondary distribution of hepatitis C self-testing within the context of a house-to-house hepatitis C micro-elimination programme in Karachi, Pakistan.
    Shilton S; Ali D; Hasnain A; Abid A; Markby J; Jamil MS; Luhmann N; Nabeta P; Ongarello S; Reipold EI; Hamid S
    BMC Public Health; 2022 Apr; 22(1):696. PubMed ID: 35397544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization's global health sector strategy core indicators and scaling up key interventions.
    Duffell EF; Hedrich D; Mardh O; Mozalevskis A
    Euro Surveill; 2017 Mar; 22(9):. PubMed ID: 28277217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.
    Ward JW; Hinman AR
    Gastroenterology; 2019 Jan; 156(2):297-310. PubMed ID: 30391470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C prevalence and elimination planning in Pakistan, a bottom-up approach accounting for provincial variation.
    Mooneyhan E; Qureshi H; Mahmood H; Tariq M; Maqbool NA; Anwar M; Aslam M; Azam F; Blach S; Khan AG; Hamid S; Hussain T; Akhter MK; Khan A; Khan U; Khowaja S; Mahmood K; Mazhar S; Nawaz A; Rose A; Ghorezai GSA; Shah S; Sarwar SZ; Razavi H
    J Viral Hepat; 2023 Apr; 30(4):345-354. PubMed ID: 36650932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.
    Alberts CJ; Clifford GM; Georges D; Negro F; Lesi OA; Hutin YJ; de Martel C
    Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):724-735. PubMed ID: 35576953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination.
    Lim AG; Qureshi H; Mahmood H; Hamid S; Davies CF; Trickey A; Glass N; Saeed Q; Fraser H; Walker JG; Mukandavire C; Hickman M; Martin NK; May MT; Averhoff F; Vickerman P
    Int J Epidemiol; 2018 Apr; 47(2):550-560. PubMed ID: 29309592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) In District Vehari, Pakistan.
    Ahmed MZ; Shahzad H; Rao T; Ali A; Samad N
    J Coll Physicians Surg Pak; 2020 May; 30(5):550-551. PubMed ID: 32580861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress on the elimination of viral hepatitis in Zimbabwe: A review of the policies, strategies and challenges.
    Dzingirai B; Katsidzira L; Matyanga CMJ; Postma MJ; van Hulst M; Mafirakureva N
    J Viral Hepat; 2021 Jul; 28(7):994-1002. PubMed ID: 33797190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study.
    Polaris Observatory Collaborators
    Lancet Gastroenterol Hepatol; 2023 Oct; 8(10):879-907. PubMed ID: 37517414
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.